Xun TANG
Founding Partner /CEO

Mr. Tang has more than 15 years of investment experience, with typical investment cases including Shanghai Lansheng Brain Hospital Group, Liangying Medical, Huaxi Bio (688363), Xinruipeng Pet Medical, Concentric Medical, and Soyuan Bio, etc. He has rich investment and industrial experience. Before founding Hosencare Brothers, Mr. Tang worked at Mitsui & Co. in Japan, a Fortune 500 company, since 2004, and was engaged in strategic investment in the consumer sector. Mr. Tang joined New Hope Group in 2009 and was responsible for overseas strategic cooperation and asset management business of various sectors and served as the front office head and managing director of Hou Sheng Investment.

Mr. Tang holds a master's degree in economics from Peking University and has been honored as one of the "2018 China's Top 10 Outstanding Venture Capitalists" by Beijing Venture Capital Association and "2015 China's Top 10 Best Emerging Investors" by Invest China.

He is also a member of the Advisory Committee for Industrial Development of West Lake Pharmaceutical College and a member of Suzhou Industrial Park Young Entrepreneurs Association.



Jianxin YANG
Founding Partner

Mr. Yang has extensive hands-on experience in fund management, corporate finance, deal structure design and exit, and co-founded Hosencare Brothers with Mr. Tang in 2017. At the same time, Mr. Yang is an early-stage investor in technology innovation companies such as Anhan Technology, Rongzhi Bio, and Faison Technology.

Prior to the establishment of Hosencare Brothers, Mr. Yang worked at Hou Sheng Investment, where he was deeply involved in the launch, fund raising and deal structuring of several USD and RMB funds. Prior to joining Hou Sheng Investment, Mr. Yang worked as a judge in a district economic court in Beijing.

Mr. Yang holds a master's degree in financial law from Peking University and is a qualified lawyer.